Follow
David Lutje Hulsik
David Lutje Hulsik
Gyes BV
Verified email at gyes.com
Title
Cited by
Cited by
Year
Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo
E Dolk, M van der Vaart, D Lutje Hulsik, G Vriend, H de Haard, S Spinelli, ...
Applied and environmental microbiology 71 (1), 442-450, 2005
1752005
Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma …
G Bodon, R Chassefeyre, K Pernet-Gallay, N Martinelli, G Effantin, ...
Journal of Biological Chemistry 286 (46), 40276-40286, 2011
1102011
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41
C Sabin, D Corti, V Buzon, MS Seaman, D Lutje Hulsik, A Hinz, ...
PLoS pathogens 6 (11), e1001195, 2010
922010
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition
D Lutje Hulsik, Y Liu, NM Strokappe, S Battella, M El Khattabi, LE McCoy, ...
PLoS pathogens 9 (3), e1003202, 2013
832013
Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C
N Strokappe, A Szynol, M Aasa-Chapman, A Gorlani, A Forsman Quigley, ...
PloS one 7 (3), e33298, 2012
742012
Heavier-than-air flying machines are impossible
L Oliveira, T Hulsen, DL Hulsik, ACM Paiva, G Vriend
FEBS letters 564 (3), 269-273, 2004
662004
Structural basis for ESCRT-III CHMP3 recruitment of AMSH
J Solomons, C Sabin, E Poudevigne, Y Usami, DL Hulsik, P Macheboeuf, ...
Structure 19 (8), 1149-1159, 2011
582011
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
E Voets, M Paradé, D Lutje Hulsik, S Spijkers, W Janssen, J Rens, ...
Journal for immunotherapy of cancer 7, 1-15, 2019
562019
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1
RPJ Lai, M Hock, J Radzimanowski, P Tonks, DL Hulsik, G Effantin, ...
Journal of Biological Chemistry 289 (43), 29912-29926, 2014
472014
Characterization of a trimeric MPER containing HIV-1 gp41 antigen
A Hinz, G Schoehn, H Quendler, DL Hulsik, G Stiegler, H Katinger, ...
Virology 390 (2), 221-227, 2009
432009
Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction
A Hinz, D Lutje Hulsik, A Forsman, WWL Koh, H Belrhali, A Gorlani, ...
PloS one 5 (5), e10482, 2010
422010
Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae
A Gorlani, D Lutje Hulsik, H Adams, G Vriend, P Hermans, T Verrips
Protein Engineering, Design & Selection 25 (1), 39-46, 2012
382012
Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodeling
A de Morrée, D Lutje Hulsik, A Impagliazzo, HH van Haagen, P de Galan, ...
PLoS One 5 (8), e11940, 2010
302010
Altered APRIL binding antibodies
H Van Eenennaam, A Van Elsas, DL Hulsik, JP Medema
US Patent 9,969,808, 2018
142018
A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing
S Huang, A Segués, DL Hulsik, DM Zaiss, AJAM Sijts, ...
Journal of immunological methods 483, 112811, 2020
112020
Anti-PD-1 antibodies
H Van Eenennaam, A Van Elsas, J Kreijtz, DL Hulsik, CRR Dos Reis
US Patent 10,494,436, 2019
82019
Anti-SIRPα antibodies
H Van Eenennaam, A Van Elsas, E Voets, V Paul, DL Hulsik
US Patent 10,851,164, 2020
72020
Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies
H Van Eenennaam, A Van Elsas, DL Hulsik, JP Medema
US Patent 10,377,830, 2019
72019
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy
L Guelen, TO Fischmann, J Wong, S Mauze, M Guadagnoli, N Bąbała, ...
Journal for Immunotherapy of Cancer 10 (9), 2022
62022
Improving properties of llama heavy chain antibodies using in silico analysis
D Lutje Hulsik
Utrecht University, 2009
42009
The system can't perform the operation now. Try again later.
Articles 1–20